Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 6, 2009, Pages 719-730

  Wietecha, Linda A ^a   Williams, David W ^a   Herbert, Michael ^b   Melmed, Raun D ^c   Greenbaum, Michael ^d   Schuh, Kory ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Utah Personnel Development Center   (United States)

^c Melmed Center   (United States)

^d Capstone Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ARTHRALGIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD DEVELOPMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FAMILY ASSESSMENT MEASURE VERSION III; FATIGUE; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; IRRITABILITY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NOSE CONGESTION; OPTIMAL DRUG DOSE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT REDUCTION; WOODCOCK JOHNSON III SCORE; YOUTH RISK BEHAVIOR SURVEY;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADOLESCENT BEHAVIOR; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77049101407     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.074     Document Type: Article

References (22)

1. Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz MI, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ: Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65:1941-1949, 2005.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Text revised. Washington (DC), American Psychiatric Association, 2000.
3. Barkley RA, Murphy KR, Kwasnik D: Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 98:1089-1095, 1996.
4. Barkley RA, Murphy KR, Dupaul GI, Bush T: Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 8:655-672, 2002.
5. Barkley RA, Fischer M, Smallish L, Fletcher K: Young adult outcome of hyperactive children: Adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:192-202, 2006.
6. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 44:269-273, 1998.
7. Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J: A randomized, double-blind study of continuation treatment for attention-deficit/ hyperactivity disorder after 1 year. Biol Psychiatry 61:694-699, 2007.
8. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations. New York, The Guilford Press, 1998.
9. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, (Maryland), US Department of Health, Education, and Welfare, 1976.
10. Hazell P, Zhang S, Wolanczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D: Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attentiondeficit/ hyperactivity disorder. Eur Child Adolesc Psychiatry 15:105-110, 2006.
11. Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ: Oncedaily atomoxetine treatment for children with attention-deficit/ hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics 114:e1-8, 2004.
12. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, Ustun TB: The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 47:565-572, 2005.
13. Maedgen JW, Carlson CL: Social functioning and emotional regulation in the attention deficit hyperactivity disorder subtypes. J Clin Child Psychol 29:30-42, 2000.
14. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T: Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 108:e83, 2001.
15. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry 159:1896-1901, 2002.
16. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D: Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 53:112-120, 2003.
17. Michelson D, Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J: Relapse prevention in pediatric patients with ADHD treated with atomoxetine: A randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 43:896-904, 2004.
18. Newcorn JH, Michelson D, Kratochvil CJ, Allen AJ, Ruff DD, Moore RJ: Low-dose atomoxetine for maintenance treatment of attentiondeficit/ hyperactivity disorder. Pediatrics 118:e1701-1706, 2006.
19. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 7:373-378, 1995.
20. Saylor K, Buermeyer C, Sutton V, Faries D, Khan S, Schuh K: The life participation scale for ADHD-child version: Psychometric properties of an adaptive change instrument. J Child Adolesc Psychopharmacol 17:831-841, 2007.
21. Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ: Results from 2 proof-of-concept, placebocontrolled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder. J Clin Psychiatry 63:1140-1147, 2002.
22. Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR: Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr 149:112-119, 2006. (Pubitemid 44081915)